Healthcare -
Biotechnology - NASDAQ - US
$ 0.5401
-6.54 %
$ 67.4 M
Market Cap
-0.33
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Vor Biopharma Inc.
| Net Income | -117 M |
| Depreciation & Amortization | 3.53 M |
| Capital Expenditures | -229 K |
| Stock-Based Compensation | 9.85 M |
| Change in Working Capital | 5 K |
| Others | 3.88 M |
| Free Cash Flow | -99.9 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (116.9) | (117.9) | (92.1) | (68.9) | (43.3) | (10.8) | (4.2) | ||
| Depreciation & Amortization | 3.5 | 3.5 | 2.5 | 1.4 | 0.6 | 91 K | 20 K | ||
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 | 32 K | 0.3 | ||
| Stock Based Compensation | 9.8 | 13.4 | 10.7 | 4.3 | 1.3 | 0.2 | 0.1 | ||
| Other Operating Activities | 3.9 | 67 K | 6.4 | 3.2 | 0.8 | 0.6 | 1.0 | ||
| Change in Working Capital | 5 K | 0.7 | (12.7) | (9.2) | 4.3 | 0.1 | 63 K | ||
| Cash From Operations | (99.7) | (100.3) | (85.1) | (69.1) | (36.3) | (9.9) | (2.7) | ||
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (345.0) | (357.0) | (307.0) | (484.0) | (359.0) | (235.0) | (215.0) | (191.0) | (107.0) |
| Other Items | (107.0) | (81.0) | (206.0) | (44.0) | (741.0) | (402.0) | 343.0 | (51.0) | (61.0) |
| Cash From Investing Activities | (452.0) | (438.0) | (513.0) | (528.0) | (1 100.0) | (637.0) | 128.0 | (242.0) | (168.0) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | (1 000.0) | (2 000.0) | (1 000.0) | (1 001.0) | (600.0) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (18.0) | 0 | (750.0) | 0 | 1 191.0 | 6 750.0 | 0 | 0 | 0 |
| Dividends Paid | (281.0) | (299.0) | (307.0) | (330.0) | (335.0) | (6 688.0) | (77.0) | (35.0) | (36.0) |
| Other Financing Activities | (42.0) | 9.0 | 0 | 461.0 | (110.0) | (1 215.0) | 1 077.0 | (1 396.0) | (877.0) |
| Cash From Financing Activities | (1 341.0) | (2 290.0) | (2 057.0) | (870.0) | 146.0 | (1 153.0) | 1 036.0 | (1 431.0) | (913.0) |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | 47.0 | (928.0) | (686.0) | 1 241.0 | 1 411.0 | 734.0 | 2 481.0 | (18.0) | 16.0 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | 1 495.0 | 1 443.0 | 1 577.0 | 2 155.0 | 2 006.0 | 2 289.0 | 1 102.0 | 1 464.0 | 990.0 |